IQVIA Holdings Inc. logo
IQVIA Holdings Inc. (IQV)
Compare

IQVIA Holdings Inc. (IQV) EV/EBITDA Ratio: 8.90x

Is IQVIA Holdings Inc.’s EV/EBITDA ratio high or low?

IQVIA Holdings Inc.'s EV/EBITDA ratio of 8.90x is 48% below its 5-year average of 17.09x, near the low end of its 5-year range (7.87x–26.79x).

The EV/EBITDA ratio for IQVIA Holdings Inc. (IQV) is 8.90x as of Wednesday, June 10, 2026. It is below its 12-month average by 32.52% (13.19x).

IQV EV/EBITDA Ratio Chart

IQV EV/EBITDA Ratio
8.90x-25.27% 1Y
Zoom

IQV Average EV/EBITDA Ratio Chart

IQV Current vs Average EV/EBITDA Ratio Chart

IQV EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

8.90x

EV/EBITDA RATIO AVG TTM

13.19x

EV/EBITDA RATIO AVG 3Y

14.98x

EV/EBITDA RATIO AVG 5Y

17.09x

EV/EBITDA RATIO AVG 10Y

18.58x

EV/EBITDA RATIO AVG 15Y

17.46x

EV/EBITDA RATIO AVG 20Y

17.46x

CURRENT VS TTM AVG

-32.52%

CURRENT VS 3Y AVG

-40.57%

CURRENT VS 5Y AVG

-47.92%

CURRENT VS 10Y AVG

-52.10%

CURRENT VS 15Y AVG

-49.03%

CURRENT VS 20Y AVG

-49.03%

IQV Competitors' EV/EBITDA Ratio

NAMEMARKET CAPEV/EBITDA RATIOTTM3Y5Y
IQVIA Holdings Inc. (IQV)8.90x13.19x14.98x17.09x
Centene Corporation (CNC)$31.94BN/A4.99x7.28x9.49x
DexCom, Inc. (DXCM)$29.24B23.24x28.10x43.48x70.03x
Biogen Inc. (BIIB)$29.00B11.60x8.56x11.16x12.22x
Veeva Systems Inc. (VEEV)$27.37B26.02x43.41x56.96x62.43x
Zoetis Inc. (ZTS)$34.20B10.33x15.67x20.68x23.76x
Waters Corporation (WAT)$23.83B38.03x21.59x21.24x21.45x
Agilent Technologies, Inc. (A)$38.26B21.51x21.11x21.69x23.12x
Mettler-Toledo International Inc. (MTD)$22.85B20.28x23.56x23.88x26.50x
BioNTech SE (BNTX)$21.81BN/A51.40x19.63x20.05x

EV/EBITDA vs. its own history

At 8.9, EV/EBITDA is cheaper than usual — richer than 1% of its 13-year range.

13-year low

7.9

median

17.1

13-year high

28.9

cheaperricher

Understanding EV/EBITDA

Enterprise Value (EV) = Market Cap + Total Debt - Cash

EBITDA = Earnings Before Interest, Taxes, Depreciation & Amortization

EV/EBITDA is commonly used for comparing companies because:

  • It accounts for debt levels (capital structure neutral)
  • It removes effects of different depreciation policies
  • It can be compared across countries with different tax rates
  • It can remain available when net income is negative, if EBITDA is positive

IQVIA Holdings Inc. EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

IQVIA Holdings Inc. EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for IQVIA Holdings Inc. (IQV)?
The EV/EBITDA ratio for IQV stock is 8.90x.
Is IQVIA Holdings Inc.'s EV/EBITDA ratio high or low?
IQVIA Holdings Inc.'s EV/EBITDA ratio of 8.90x is 48% below its 5-year average of 17.09x, near the low end of its 5-year range (7.87x–26.79x).
What is the TTM average EV/EBITDA ratio for IQVIA Holdings Inc. (IQV)?
The TTM average EV/EBITDA ratio for IQV stock is 13.19x.
What is the 3Y average EV/EBITDA ratio for IQVIA Holdings Inc. (IQV)?
The 3Y average EV/EBITDA ratio for IQV stock is 14.98x.
What is the 5Y average EV/EBITDA ratio for IQVIA Holdings Inc. (IQV)?
The 5Y average EV/EBITDA ratio for IQV stock is 17.09x.
What is the 10Y average EV/EBITDA ratio for IQVIA Holdings Inc. (IQV)?
The 10Y average EV/EBITDA ratio for IQV stock is 18.58x.
What is the 15Y average EV/EBITDA ratio for IQVIA Holdings Inc. (IQV)?
The 15Y average EV/EBITDA ratio for IQV stock is 17.46x.
What is the 20Y average EV/EBITDA ratio for IQVIA Holdings Inc. (IQV)?
The 20Y average EV/EBITDA ratio for IQV stock is 17.46x.

IQVIA Holdings Inc. EV/EBITDA Ratio History

DATEEV/EBITDA RATIO
2026-06-108.90x
2026-06-099.04x
2026-06-088.92x
2026-06-058.90x
2026-06-049.07x
2026-06-038.84x
2026-06-028.77x
2026-06-019.07x
2026-05-298.84x
2026-05-288.79x
2026-05-278.04x
2026-05-267.87x
2026-05-228.15x
2026-05-218.16x
2026-05-208.33x
2026-05-198.41x
2026-05-188.39x
2026-05-158.21x
2026-05-148.29x
2026-05-138.37x
2026-05-128.50x
2026-05-118.43x
2026-05-088.67x
2026-05-078.67x
2026-05-068.57x
2026-05-058.56x
2026-05-0412.08x
2026-05-0111.93x
2026-04-3011.96x
2026-04-2911.87x
2026-04-2811.99x
2026-04-2712.23x
2026-04-2412.15x
2026-04-2312.07x
2026-04-2212.79x
2026-04-2112.82x
2026-04-2012.87x
2026-04-1712.85x
2026-04-1612.63x
2026-04-1512.94x
2026-04-1412.80x
2026-04-1312.63x
2026-04-1012.40x
2026-04-0912.48x
2026-04-0812.66x
2026-04-0712.56x
2026-04-0612.57x
2026-04-0212.70x
2026-04-0112.65x
2026-03-3112.56x
2026-03-3012.34x
2026-03-2712.23x
2026-03-2612.50x
2026-03-2512.32x
2026-03-2412.34x
2026-03-2312.38x
2026-03-2012.34x
2026-03-1912.36x
2026-03-1812.39x
2026-03-1712.46x
2026-03-1612.28x
2026-03-1312.27x
2026-03-1212.18x
2026-03-1112.61x
2026-03-1012.58x
2026-03-0912.96x
2026-03-0612.76x
2026-03-0512.96x
2026-03-0412.92x
2026-03-0312.73x
2026-03-0212.75x
2026-02-2712.97x
2026-02-2612.57x
2026-02-2512.13x
2026-02-2412.28x
2026-02-2312.15x
2026-02-2012.32x
2026-02-1912.50x
2026-02-1812.59x
2026-02-1712.26x
2026-02-1312.24x
2026-02-1212.33x
2026-02-1112.75x
2026-02-1013.01x
2026-02-0913.52x
2026-02-0613.27x
2026-02-0512.94x
2026-02-0414.02x
2026-02-0314.08x
2026-02-0215.45x
2026-01-3015.40x
2026-01-2915.67x
2026-01-2815.88x
2026-01-2715.94x
2026-01-2615.86x
2026-01-2315.66x
2026-01-2215.84x
2026-01-2115.96x
2026-01-2015.58x
2026-01-1615.77x
2026-01-1515.95x
2026-01-1415.96x
2026-01-1315.97x
2026-01-1215.93x
2026-01-0916.01x
2026-01-0816.05x
2026-01-0716.10x
2026-01-0615.92x
2026-01-0515.62x
2026-01-0215.16x
2025-12-3115.16x
2025-12-3015.28x
2025-12-2915.25x
2025-12-2615.24x
2025-12-2415.19x
2025-12-2315.15x
2025-12-2215.11x
2025-12-1914.93x
2025-12-1815.02x
2025-12-1714.96x
2025-12-1614.97x
2025-12-1515.07x
2025-12-1215.00x
2025-12-1115.19x
2025-12-1015.04x
2025-12-0914.79x
2025-12-0815.07x
2025-12-0515.18x
2025-12-0415.14x
2025-12-0315.25x
2025-12-0215.17x
2025-12-0115.31x
2025-11-2815.39x
2025-11-2615.48x
2025-11-2515.49x
2025-11-2415.30x
2025-11-2115.14x
2025-11-2014.75x
2025-11-1914.76x
2025-11-1814.75x
2025-11-1714.70x
2025-11-1414.92x
2025-11-1315.07x
2025-11-1214.93x
2025-11-1114.82x
2025-11-1014.54x
2025-11-0714.41x
2025-11-0614.43x
2025-11-0514.40x
2025-11-0414.44x
2025-11-0314.58x
2025-10-3114.71x
2025-10-3014.71x
2025-10-2914.78x
2025-10-2814.80x
2025-10-2715.32x
2025-10-2415.48x
2025-10-2315.45x
2025-10-2215.35x
2025-10-2115.39x
2025-10-2015.05x
2025-10-1714.66x
2025-10-1614.72x
2025-10-1514.58x
2025-10-1414.67x
2025-10-1314.62x
2025-10-1014.33x
2025-10-0914.58x
2025-10-0814.45x
2025-10-0714.47x
2025-10-0614.68x
2025-10-0314.77x
2025-10-0214.65x
2025-10-0114.62x
2025-09-3013.90x
2025-09-2913.43x
2025-09-2613.37x
2025-09-2513.22x
2025-09-2413.45x
2025-09-2313.72x
2025-09-2213.79x
2025-09-1913.76x
2025-09-1813.92x
2025-09-1713.73x
2025-09-1613.74x
2025-09-1513.70x
2025-09-1213.76x
2025-09-1113.94x
2025-09-1013.59x
2025-09-0913.89x
2025-09-0813.79x
2025-09-0513.79x
2025-09-0413.60x
2025-09-0313.63x
2025-09-0213.58x
2025-08-2913.95x
2025-08-2813.84x
2025-08-2713.84x
2025-08-2613.79x
2025-08-2513.80x
2025-08-2213.96x
2025-08-2113.67x
2025-08-2014.01x
2025-08-1914.03x
2025-08-1814.04x
2025-08-1513.96x
2025-08-1413.87x
2025-08-1313.92x
2025-08-1213.69x
2025-08-1113.39x
2025-08-0813.38x
2025-08-0713.33x
2025-08-0613.26x
2025-08-0513.59x
2025-08-0413.53x
2025-08-0113.51x
2025-07-3113.69x
2025-07-3013.98x
2025-07-2914.14x
2025-07-2814.31x
2025-07-2514.38x
2025-07-2414.46x
2025-07-2314.12x
2025-07-2213.77x
2025-07-2111.87x
2025-07-1811.96x
2025-07-1712.09x
2025-07-1611.85x
2025-07-1511.81x
2025-07-1411.93x
2025-07-1112.07x
2025-07-1012.21x
2025-07-0912.03x
2025-07-0812.15x
2025-07-0712.05x
2025-07-0312.14x
2025-07-0212.16x
2025-07-0112.06x
2025-06-3011.80x
2025-06-2711.79x
2025-06-2611.83x
2025-06-2511.86x
2025-06-2411.85x
2025-06-2311.68x
2025-06-2011.65x
2025-06-1811.65x
2025-06-1711.62x
2025-06-1611.89x
2025-06-1311.76x
2025-06-1211.88x
2025-06-1111.86x
2025-06-1011.91x
2025-06-0911.62x
2025-06-0611.53x
2025-06-0511.28x
2025-06-0411.30x
2025-06-0311.04x
2025-06-0210.85x
2025-05-3010.91x
2025-05-2910.95x

Showing the most recent 260 of 3,292 data points. The chart above shows the full history.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Durham, NC
89,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ari Bousbib